Agenus, Inc. (AGEN)
3.07
-0.04
(-1.29%)
USD |
NASDAQ |
Jun 10, 16:00
3.09
+0.02
(+0.65%)
After-Hours: 07:54
Agenus 1 Year Total Returns (Daily) : -42.83% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -42.83% |
| June 09, 2026 | -43.96% |
| June 08, 2026 | -47.23% |
| June 05, 2026 | -37.40% |
| June 04, 2026 | -39.70% |
| June 03, 2026 | -35.60% |
| June 02, 2026 | -18.16% |
| June 01, 2026 | 1.46% |
| May 29, 2026 | 9.38% |
| May 28, 2026 | 12.58% |
| May 27, 2026 | -3.94% |
| May 26, 2026 | -13.09% |
| May 22, 2026 | -17.94% |
| May 21, 2026 | -13.66% |
| May 20, 2026 | -17.97% |
| May 19, 2026 | -18.47% |
| May 18, 2026 | -9.20% |
| May 15, 2026 | 5.92% |
| May 14, 2026 | 3.17% |
| May 13, 2026 | 2.66% |
| May 12, 2026 | -1.71% |
| May 11, 2026 | 12.03% |
| May 08, 2026 | 25.66% |
| May 07, 2026 | 27.12% |
| May 06, 2026 | 30.98% |
| Date | Value |
|---|---|
| May 05, 2026 | 34.95% |
| May 04, 2026 | 29.26% |
| May 01, 2026 | 34.27% |
| April 30, 2026 | 35.29% |
| April 29, 2026 | 25.90% |
| April 28, 2026 | 23.89% |
| April 27, 2026 | 51.48% |
| April 24, 2026 | 38.30% |
| April 23, 2026 | 31.93% |
| April 22, 2026 | 37.28% |
| April 21, 2026 | 69.26% |
| April 20, 2026 | 112.5% |
| April 17, 2026 | 130.3% |
| April 16, 2026 | 181.2% |
| April 15, 2026 | 185.8% |
| April 14, 2026 | 165.2% |
| April 13, 2026 | 144.1% |
| April 10, 2026 | 144.4% |
| April 09, 2026 | 158.0% |
| April 08, 2026 | 147.1% |
| April 07, 2026 | 120.7% |
| April 06, 2026 | 141.7% |
| April 02, 2026 | 104.3% |
| April 01, 2026 | 112.5% |
| March 31, 2026 | 121.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Iovance Biotherapeutics, Inc. | 58.82% |
| AnaptysBio, Inc. | 226.1% |
| Amarin Corp. Plc | 15.13% |
| Inovio Pharmaceuticals, Inc. | -51.56% |
| Vertex Pharmaceuticals, Inc. | -3.50% |